Companies / Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc.

NYSE: LCTXCIK 876343CARLSBAD, CAlineagecell.com ↗

Financials · FY2025

Revenue$14.56M
Net income$-63.53M
Total debt—
Cash$37.35M
Diluted EPS$-0.28
Shares outstanding252.9M

Ownership

252.9M shares outstanding · as of Aug 3, 2026
0.11%Insiders
Ownership
Insiders0.11%286,579
Institutions46.26%116,987,628
Public float53.63%135,633,257

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Culley Brian MCEOPresident and CEO · Director
0.10%255,516
Samuel George A. IIIGeneral Counsel and Secretary
0.01%31,063
Howe Jill AnnChief Financial Officer
——

Institutional holders 124

View all →
HolderValue% of shares
Broadwood Capital Inc$78.31M19.60%
BlackRock, Inc.$17.27M5.21%
Vanguard Group Inc$16.11M3.81%
Defender Capital, LLC.$11.41M2.70%
Millennium Management LLC$8.79M2.20%
Raffles Associates LP$8.47M2.12%
Comerica Bank$7.68M1.82%
Marshall Wace, LLP$4.84M1.21%
Geode Capital Management, LLC$3.99M1.00%
Renaissance Technologies LLC$3.36M0.84%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$12.25M+9.4M
+243.94%
13,186,895
5.21% of shares
medium
Q1 2026
as of
Millennium Management LLC
13F manager
AddCommon Stock$5.45M+3.5M
+163.52%
5,561,374
2.20% of shares
medium
Q1 2026
as of
Marshall Wace, LLP
13F manager
AddCommon Stock$2.69M+1.7M
+125.03%
3,065,033
1.21% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
AddCommon Stock$1.70M+1.3M
+127.73%
2,314,180
0.92% of shares
low
Q4 2025
as of
Barclays PLC
13F manager
AddCommon Stock$582.0K+349K
+34850900.00%
348,510
0.14% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
TrimCommon Stock$-441.9K-280K
-11.63%
2,125,100
0.84% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
TrimCommon Stock$-279.7K-177K
-66.65%
88,585
0.04% of shares
low
Q1 2026
as of
OMERS Administration Corporation
13F manager
TrimCommon Stock$-275.2K-174K
-61.51%
109,000
0.04% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
LCTXCommon StockEquity53566P109BBG000G8RJY6